Editor’s note: This is not an exhaustive list. Drugmakers are listed in alphabetical order.
- AbbVie waived license restrictions on an HIV drug that may treat COVID-19. The drugmaker also pushed back its takeover of Allergan to May due to disruptions caused by the COVID-19 pandemic.
- Bayer fired an employee who broke quarantine rules in Beijing, China.
- Eli Lilly capped insulin costs at $35 per month in an effort to help patients afford the drug during the COVID-19 pandemic.
- Gilead asked the FDA to take back orphan drug status for its experimental drug, remdesivir, which is being tested to treat COVID-19. It also boosted production of remdesivir and had 1.5 million doses as of April 4.
- Johnson & Johnson partnered with the U.S. government to develop a vaccine for COVID-19, with the government investing $1 billion.
- Mylan delayed its merger with Upjohn until the second half of this year because of unexpected delays caused by the coronavirus pandemic.
- Novartis said it plans to conduct a 440-person clinical trial to determine the effectiveness of hydroxychloroquine against COVID-19.
- Novo Nordisk offered a free 90-day supply of insulin to patients who were financially affected by the COVID-19 pandemic.
- Regeneron teamed up with Sanofi to launch clinical trials to see if a drug they co-developed can treat symptoms of COVID-19.
- Rising Pharmaceuticals, a New Jersey-based drugmaker, slashed the price of its chloroquine tablets, a drug that may treat COVID-19, by more than half.
- Pfizer identified a lead COVID-19 drug candidate that it hopes to start testing on humans in the summer.
- Sage Therapeutics, a Massachusetts-based drugmaker, cut 53 percent of its workforce in an effort to save money.
- Sanofi partnered with GlaxoSmithKline to create a COVID-19 vaccine with funding from HHS.
More articles on pharmacy:
CVS, UCLA Health unite to free hospital beds for COVID-19 patients
NIH teams up with 16 drugmakers to speed COVID-19 vaccine development
16 recent drug, device recalls
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.